Literature DB >> 8914758

Specific antibody reactivity against a 110-kilodalton Actinobacillus actinomycetemcomitans protein in subjects with periodontitis.

T F Fleming1, I Selmair, H Schmidt, H Karch.   

Abstract

The purpose of the present study was to determine the serum immunoglobulin A (IgA), IgM, and IgG reactivities against proteins of Actinobacillus actinomycetemcomitans in patients with periodontitis. Serum samples from 20 patients with early-onset periodontitis, 20 patients with adult periodontitis, and 20 age- and sex-matched healthy controls were assessed by immunoblot analysis. IgG antibody reactivity against a sarcosyl-insoluble 110-kDa protein of A. actinomycetemcomitans was detected in 65 and 45% of patients with early-onset periodontitis and adult peritonitis, respectively, and IgA antibodies against this protein were found in 70 and 55% of these patients, respectively. However, control subjects showed no IgG reactivity, and IgA antibodies against the sarcosyl-insoluble 110-kDa protein were detected in only 5% of the patients (P < 0.05). There was no IgM antibody reactivity against this protein in any of the diseased or healthy subjects. The sensitivity and specificity of serum IgA antibody reactivity against the 110-kDa protein in detecting subgingival A. actinomycetemcomitans infection, as determined by PCR, were 77 and 66%, respectively. The results of the study indicated that the sarcosyl-insoluble 110-kDa protein is a potential candidate for use in the serodiagnosis of periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914758      PMCID: PMC170430          DOI: 10.1128/cdli.3.6.678-681.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  33 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease.

Authors:  J L Ebersole; M N Sandoval; M J Steffen; D Cappelli
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Outer membrane proteins of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus studied by SDS-PAGE and immunoblotting.

Authors:  A I Bolstad; T Kristoffersen; I Olsen; H R Preus; H B Jesen; E N Vasstrand; V Bakken
Journal:  Oral Microbiol Immunol       Date:  1990-06

4.  Analysis of site specific periodontal bacteria sampling schemes.

Authors:  J C Gunsolley; V N Chinchilli; E D Savitt; W Killoy; A P Darack; L A Christersson; C F Fransson; R G Dunford; J J Zambon
Journal:  J Periodontol       Date:  1992-06       Impact factor: 6.993

5.  IgG antibody response of localized juvenile periodontitis patients to the 29 kilodalton outer membrane protein of Actinobacillus actinomycetemcomitans.

Authors:  M E Wilson
Journal:  J Periodontol       Date:  1991-03       Impact factor: 6.993

6.  Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.

Authors:  C Filip; G Fletcher; J L Wulff; C F Earhart
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

7.  Subgingival distribution of periodontal pathogenic microorganisms in adult periodontitis.

Authors:  L A Christersson; C L Fransson; R G Dunford; J J Zambon
Journal:  J Periodontol       Date:  1992-05       Impact factor: 6.993

8.  The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.

Authors:  U Enders; H Karch; K V Toyka; M Michels; J Zielasek; M Pette; J Heesemann; H P Hartung
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

9.  Fc-binding components: a virulence factor in Actinobacillus actinomycetemcomitans?

Authors:  K Tolo; K Helgeland
Journal:  Oral Microbiol Immunol       Date:  1991-12

10.  Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27.

Authors:  P Kiley; S C Holt
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.